New Haven-based Halda Therapeutics to be acquired for $3 billion by Johnson & Johnson
Johnson & Johnson's planned $3 billion acquisition of Halda Therapeutics is one of the largest deals for a CT-based biotech company. |!| New Haven
Johnson & Johnson's planned $3 billion acquisition of Halda Therapeutics is one of the largest deals for a CT-based biotech company. |!| New Haven